http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 13 Mar 2024 17:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Announces+Transfer+of+Listing+to+NEX+and+New+Stock+Option+Plan/22927604.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Announces+Transfer+of+Listing+to+NEX+and+New+Stock+Option+Plan/22927604.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Announces+Transfer+of+Listing+to+NEX+and+New+Stock+Option+Plan/22927604.html Wed, 13 Mar 2024 17:15:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Announces+Transfer+of+Listing+to+NEX+and+New+Stock+Option+Plan/22927604.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Announces+Transfer+of+Listing+to+NEX+and+New+Stock+Option+Plan/22927604.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Announces+Transfer+of+Listing+to+NEX+and+New+Stock+Option+Plan/22927604.html Wed, 13 Mar 2024 17:15:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Cease+Trade+Order/22894083.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Cease+Trade+Order/22894083.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Cease+Trade+Order/22894083.html Wed, 06 Mar 2024 14:45:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Cease+Trade+Order/22894083.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Cease+Trade+Order/22894083.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Cease+Trade+Order/22894083.html Wed, 06 Mar 2024 14:45:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Its+Expected+Delay+in+Filing+Annual+Audited+Financial+Statements+and+Annual+Information+Form/22835499.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Its+Expected+Delay+in+Filing+Annual+Audited+Financial+Statements+and+Annual+Information+Form/22835499.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Its+Expected+Delay+in+Filing+Annual+Audited+Financial+Statements+and+Annual+Information+Form/22835499.html Mon, 26 Feb 2024 19:38:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Its+Expected+Delay+in+Filing+Annual+Audited+Financial+Statements+and+Annual+Information+Form/22835499.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Its+Expected+Delay+in+Filing+Annual+Audited+Financial+Statements+and+Annual+Information+Form/22835499.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Its+Expected+Delay+in+Filing+Annual+Audited+Financial+Statements+and+Annual+Information+Form/22835499.html Mon, 26 Feb 2024 19:38:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Announces+Stock+Option+Grant/22743817.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Announces+Stock+Option+Grant/22743817.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Announces+Stock+Option+Grant/22743817.html Thu, 08 Feb 2024 16:35:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Announces+Stock+Option+Grant/22743817.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Announces+Stock+Option+Grant/22743817.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Announces+Stock+Option+Grant/22743817.html Thu, 08 Feb 2024 16:35:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Receives+Conditional+Approval+to+List+on+the+TSX+Venture+Exchange/22583943.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Receives+Conditional+Approval+to+List+on+the+TSX+Venture+Exchange/22583943.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+International+Inc.+Receives+Conditional+Approval+to+List+on+the+TSX+Venture+Exchange/22583943.html Tue, 02 Jan 2024 17:40:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Receives+Conditional+Approval+to+List+on+the+TSX+Venture+Exchange/22583943.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Receives+Conditional+Approval+to+List+on+the+TSX+Venture+Exchange/22583943.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+International+Inc.+Receives+Conditional+Approval+to+List+on+the+TSX+Venture+Exchange/22583943.html Tue, 02 Jan 2024 17:40:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Third+Quarter+2023+Results/22277849.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Third+Quarter+2023+Results/22277849.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Third+Quarter+2023+Results/22277849.html Mon, 16 Oct 2023 17:23:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Third+Quarter+2023+Results/22277849.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Third+Quarter+2023+Results/22277849.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Third+Quarter+2023+Results/22277849.html Mon, 16 Oct 2023 17:23:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Reports+Director+Election+Results/22163998.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Reports+Director+Election+Results/22163998.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Reports+Director+Election+Results/22163998.html Thu, 14 Sep 2023 17:00:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Reports+Director+Election+Results/22163998.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Reports+Director+Election+Results/22163998.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Reports+Director+Election+Results/22163998.html Thu, 14 Sep 2023 17:00:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Second+Quarter+2023+Results/21910296.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Second+Quarter+2023+Results/21910296.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Second+Quarter+2023+Results/21910296.html Fri, 14 Jul 2023 16:05:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Second+Quarter+2023+Results/21910296.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Second+Quarter+2023+Results/21910296.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Second+Quarter+2023+Results/21910296.html Fri, 14 Jul 2023 16:05:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Third+Quarter+2022+Results/20705326.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Third+Quarter+2022+Results/20705326.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Third+Quarter+2022+Results/20705326.html Fri, 14 Oct 2022 16:15:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Third+Quarter+2022+Results/20705326.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Third+Quarter+2022+Results/20705326.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Third+Quarter+2022+Results/20705326.html Fri, 14 Oct 2022 16:15:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Signs+an+Exclusive+License+%26+Supply+Agreement+with+Taro+Pharmaceuticals+Inc.+for+Desvenlafaxine+Extended-Release+Tablets/20471820.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Signs+an+Exclusive+License+%26+Supply+Agreement+with+Taro+Pharmaceuticals+Inc.+for+Desvenlafaxine+Extended-Release+Tablets/20471820.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Signs+an+Exclusive+License+%26+Supply+Agreement+with+Taro+Pharmaceuticals+Inc.+for+Desvenlafaxine+Extended-Release+Tablets/20471820.html Tue, 16 Aug 2022 08:00:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Signs+an+Exclusive+License+%26+Supply+Agreement+with+Taro+Pharmaceuticals+Inc.+for+Desvenlafaxine+Extended-Release+Tablets/20471820.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Signs+an+Exclusive+License+%26+Supply+Agreement+with+Taro+Pharmaceuticals+Inc.+for+Desvenlafaxine+Extended-Release+Tablets/20471820.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Signs+an+Exclusive+License+%26+Supply+Agreement+with+Taro+Pharmaceuticals+Inc.+for+Desvenlafaxine+Extended-Release+Tablets/20471820.html Tue, 16 Aug 2022 08:00:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Second+Quarter+2022+Results/20353028.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Second+Quarter+2022+Results/20353028.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Second+Quarter+2022+Results/20353028.html Thu, 21 Jul 2022 14:50:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Second+Quarter+2022+Results/20353028.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Second+Quarter+2022+Results/20353028.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Second+Quarter+2022+Results/20353028.html Thu, 21 Jul 2022 14:50:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Delay+in+Filing+Second+Quarter+Results+Due+July+15%2C+2022%2C+The+Financial+Statements+Will+be+Filed+By+July+21%2C+2022/20329816.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Delay+in+Filing+Second+Quarter+Results+Due+July+15%2C+2022%2C+The+Financial+Statements+Will+be+Filed+By+July+21%2C+2022/20329816.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Announces+Delay+in+Filing+Second+Quarter+Results+Due+July+15%2C+2022%2C+The+Financial+Statements+Will+be+Filed+By+July+21%2C+2022/20329816.html Fri, 15 Jul 2022 08:00:00 -0400 IPCIF http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Delay+in+Filing+Second+Quarter+Results+Due+July+15%2C+2022%2C+The+Financial+Statements+Will+be+Filed+By+July+21%2C+2022/20329816.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Delay+in+Filing+Second+Quarter+Results+Due+July+15%2C+2022%2C+The+Financial+Statements+Will+be+Filed+By+July+21%2C+2022/20329816.html for the full story. http://www.streetinsider.com/Accesswire/Intellipharmaceutics+Announces+Delay+in+Filing+Second+Quarter+Results+Due+July+15%2C+2022%2C+The+Financial+Statements+Will+be+Filed+By+July+21%2C+2022/20329816.html Fri, 15 Jul 2022 08:00:00 -0400 IPCIF http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Reports+Director+Election+Results/20145634.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Reports+Director+Election+Results/20145634.html for the full story. http://www.streetinsider.com/Press+Releases/Intellipharmaceutics+Reports+Director+Election+Results/20145634.html Fri, 27 May 2022 16:45:00 -0400 IPCIF